BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35302435)

  • 1. Production of codon-optimized
    Dewi KS; Chairunnisa S; Swasthikawati S; Yuliawati ; Agustiyanti DF; Mustopa AZ; Kusharyoto W; Ningrum RA
    Prep Biochem Biotechnol; 2023; 53(2):148-156. PubMed ID: 35302435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris.
    Sanchooli A; Aghaiypour K; Kiasari BA; Samarbaf-Zadeh A; Ghadiri A; Makvandi M
    Protein Pept Lett; 2018; 25(8):783-790. PubMed ID: 30091403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification, and characterization of self-assembly virus-like particles of capsid protein L1 HPV 52 in Pichia pastoris GS115.
    Rosmeita CN; Budiarti S; Mustopa AZ; Novianti E; Swasthikawati S; Chairunnisa S; Hertati A; Nurfatwa M; Ekawati N; Hasan N
    J Genet Eng Biotechnol; 2023 Nov; 21(1):126. PubMed ID: 37981617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of L1 protein from different types of HPV in Pichia pastoris using an integrative vector.
    Coimbra EC; Gomes FB; Campos JF; D'arc M; Carvalho JC; Mariz FC; Jesus AL; Stocco RC; Beçak W; Freitas AC
    Braz J Med Biol Res; 2011 Dec; 44(12):1209-14. PubMed ID: 22030867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene optimization is necessary to express HPV type 6 L1 protein in the methylotrophic yeast Pichia pastoris].
    Li PC; Zhang XG; Zhou L; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):310-4. PubMed ID: 15340539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction, expression, and in vitro assembly of virus-like particles of L1 protein of human papillomavirus type 52 in Escherichia coli BL21 DE3.
    Mustopa AZ; Meilina L; Irawan S; Ekawati N; Fathurahman AT; Triratna L; Kusumawati A; Prastyowati A; Nurfatwa M; Hertati A; Harmoko R
    J Genet Eng Biotechnol; 2022 Feb; 20(1):19. PubMed ID: 35132511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania.
    Bolhassani A; Muller M; Roohvand F; Motevalli F; Agi E; Shokri M; Rad MM; Hosseinzadeh S
    Hum Vaccin Immunother; 2014; 10(12):3499-508. PubMed ID: 25668661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.
    Bazan SB; de Alencar Muniz Chaves A; Aires KA; Cianciarullo AM; Garcea RL; Ho PL
    Arch Virol; 2009; 154(10):1609-17. PubMed ID: 19756360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization and immunological properties of Pichia pastoris based HPV16L1 and 18L1 virus like particles.
    Gupta G; Glueck R; Rishi N
    Biologicals; 2017 Mar; 46():11-22. PubMed ID: 28012703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of unique chimeric human papilloma virus type 16 (HPV-16) L1-L2 proteins in Pichia pastoris and Hansenula polymorpha.
    Bredell H; Smith JJ; Görgens JF; van Zyl WH
    Yeast; 2018 Sep; 35(9):519-529. PubMed ID: 29709079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization, characterization, comparison of self-assembly VLP of capsid protein L1 in yeast and reverse vaccinology design against human papillomavirus type 52.
    Firdaus MER; Mustopa AZ; Ekawati N; Chairunnisa S; Arifah RK; Hertati A; Irawan S; Prastyowati A; Kusumawati A; Nurfatwa M
    J Genet Eng Biotechnol; 2023 May; 21(1):68. PubMed ID: 37222880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an IP-Free Biotechnology Platform for Constitutive Production of HPV16 L1 Capsid Protein Using the Pichia pastoris PGK1 Promoter.
    Mariz FC; Coimbra EC; Jesus AL; Nascimento LM; Torres FA; Freitas AC
    Biomed Res Int; 2015; 2015():594120. PubMed ID: 26090426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine.
    Gupta G; Giannino V; Rishi N; Glueck R
    Vaccine; 2016 Sep; 34(39):4724-4731. PubMed ID: 27523740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the bovine papillomavirus type 1, 2 and 4 L1 genes in the yeast Pichia pastoris.
    Jesus AL; Mariz FC; Souza HM; Cordeiro MN; Coimbra EC; Leitão MC; Nascimento LM; Stocco RC; Beçak W; Freitas AC
    Genet Mol Res; 2012 Aug; 11(3):2598-607. PubMed ID: 22869085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
    Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
    Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing of DNA Vaccine Based on a Secretory Form of Major Capsid Protein of Human Papillomavirus Type 18.
    Shokri S; Mahmoudvand S; Makvandi M; Taherkhani R; Rashno M; Azizi Jalilian F; Ahmadi Angali K; Foroughi MA
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):525-536. PubMed ID: 34664812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines.
    Ahmed AI; Bissett SL; Beddows S
    Infect Genet Evol; 2013 Aug; 18():151-9. PubMed ID: 23722024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.